Your browser doesn't support javascript.
loading
Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study.
Omarjee, Loukman; Le Pabic, Estelle; Custaud, Marc-Antoine; Fontaine, Cédric; Locher, Clara; Renault, Alain; Jaquinandi, Vincent; Azzola, Vincent; Barbeau-Terrier, Céline; Laporte, Isabelle; Ripoche, Manuela; Onillon, Yoanna; Chretien, Jean-Marie; Daniel, Valérie; Chao de la Barca, Juan-Manuel; Homedan, Chadi; Reynier, Pascal; Abraham, Pierre; Mahé, Guillaume.
Afiliação
  • Omarjee L; Univ Rennes, CHU Rennes, INSERM CIC1414, Vascular Medicine Unit, F-35000 Rennes, France; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France; Vascular Medicine Unit, Redon Hospital, 8 Rue Etienne Gascon, 35600 Redon, France. Electronic address: loukmano@yahoo.fr.
  • Le Pabic E; Univ Rennes, CHU Rennes, INSERM CIC1414, Clinical Investigation Center, F-35000 Rennes, France.
  • Custaud MA; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France; Center for Clinical Research, Angers University Hospital, France.
  • Fontaine C; Vascular Medicine Unit, Centre Hospitalier de Cholet, 49325 Cholet, Cedex, France.
  • Locher C; Univ Rennes, CHU Rennes, INSERM CIC1414, Clinical Investigation Center, F-35000 Rennes, France.
  • Renault A; Univ Rennes, CHU Rennes, INSERM CIC1414, Clinical Investigation Center, F-35000 Rennes, France.
  • Jaquinandi V; Univ Rennes, CHU Rennes, INSERM CIC1414, Vascular Medicine Unit, F-35000 Rennes, France.
  • Azzola V; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Barbeau-Terrier C; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Laporte I; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Ripoche M; Center for Clinical Research, Angers University Hospital, France.
  • Onillon Y; Delegation for Clinical Research and Innovation, Angers University Hospital, France.
  • Chretien JM; Delegation for Clinical Research and Innovation, Angers University Hospital, France.
  • Daniel V; Pharmacy, Angers University Hospital, France.
  • Chao de la Barca JM; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Homedan C; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Reynier P; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Abraham P; MitoVasc Institute, UMR CNRS 6015 - INSERM U1083, CHU, Angers, France.
  • Mahé G; Univ Rennes, CHU Rennes, INSERM CIC1414, Vascular Medicine Unit, F-35000 Rennes, France.
Vascul Pharmacol ; 118-119: 106563, 2019.
Article em En | MEDLINE | ID: mdl-31152977
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Caminhada / Tolerância ao Exercício / Doença Arterial Periférica / Inibidores da Fosfodiesterase 5 / Citrato de Sildenafila / Claudicação Intermitente Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Vascul Pharmacol Assunto da revista: ANGIOLOGIA / FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Caminhada / Tolerância ao Exercício / Doença Arterial Periférica / Inibidores da Fosfodiesterase 5 / Citrato de Sildenafila / Claudicação Intermitente Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Vascul Pharmacol Assunto da revista: ANGIOLOGIA / FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article